Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
MORRIS PLAINS, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]